Buvidal®. Free Clinical Update: Special Edition
Buvidal®. Free Clinical Update: Special Edition
This Clinical Update focuses on the new prolonged release subcutaneous buprenorphine injection for opioid use disorder .
The purpose of this update is not to summarise the pharmacological properties of Buvidal®, nor to explain in detail how it works. For this the summary of product characteristics can be consulted (see links below). Instead this update evaluates the evidence base for Buvidal®. Three studies are summarised with individual commentary on the results of each study. A wider discussion then follows about the clinical implications of this exciting new technology. (Substance Misuse Management in General Practice (SMMGP), UK, 17.06.2019)
https://www.smmgp-fdap.org.uk/news/free-clinical-update-special-edition